A new study highlights that individuals using prohibited psychedelics like psilocybin or LSD show a significantly higher risk of death within five years compared to the general Canadian population. The rise in psychedelic use is stark, doubling in the U.S. over five years, and trends suggest many Canadians are exploring these substances for mental health treatment. Dr. Daniel Myran's research sheds light on the urgent need for further investigation into the potential long-term impacts of psychedelics as their popularity in therapeutic settings increases amidst ongoing debates about their safety and efficacy.
People who take prohibited psychedelics such as psilocybin or LSD and go to the emergency department for care show a higher risk of death within five years.
The study reveals alarming statistics about the increased use of psychedelics and their associated long-term risks, underscoring the need for more research.
Dr. Daniel Myran emphasized the hype surrounding psychedelic-assisted therapy, noting that while there is excitement, there's also a critical need for understanding effects and risks.
While psychedelics are gaining traction for their potential in treating mental health disorders, there is growing concern about the long-term consequences of their use.
Collection
[
|
...
]